Dixon, J B
Egger, G J
Finkelstein, E A
Kral, J G
Lambert, G W
Article History
Received: 18 December 2013
Accepted: 26 January 2014
First Online: 15 April 2014
Competing interests
: JD has received research funding and support from Allergan Inc. He is on the Optifast<sup>®</sup> Medical Advisory Board for Nestlé Australia and has received consultancy fees from Allergan Inc, Metagenics, and iNova Pharmaceuticals. EF has acted as a consultant for Allergan Inc. in the past and currently does consulting work for Jenny Craig and Vivus Inc. G.L.’s laboratory currently receives commercial research grant funding from Medtronic (formerly ARDIAN Inc.), Servier Australia, Abbott (formerly Solvay) and Allergan Inc.; he has acted as a consultant for Medtronic and has received honoraria or travel support for presentations from Pfizer, Wyeth Pharmaceuticals, Servier and Medtronic. GE and JK have no conflict of interest to declare.